Search the Newsreel

CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday

CNH Industrial (NYSE: CNH) shares surged after reporting better-than-expected Q2 earnings and raising its FY26 adjusted EPS guidance. Several other stocks, including Atkore Inc (NYSE: ATKR), Autolus Therapeutics PLC (NASDAQ: AUTL), and Newell Brands Inc (NASDAQ: NWL), also saw significant gains following positive financial …

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

METTLER TOLEDO Introduces LightningBuild Program For Four-Week Delivery

METTLER TOLEDO Product Inspection Group has launched its new LightningBuild program, offering a four-week delivery time for select product inspection systems. The program currently includes the X12 LightningBuild x-ray inspection system and the C31 LightningBuild checkweigher, designed to help food and pharmaceutical manufacturers quickly …

Autoliv, Inc. Announces Quarterly Dividend of $0.87 (NYSE:ALV)

Autoliv, Inc. (NYSE:ALV) announced a quarterly dividend of $0.87 per share, payable on September 15th to shareholders of record by August 28th. This dividend represents an annual payout of $3.48 and a yield of 2.9%, with a sustainable payout ratio of 33.1%. Despite slightly …

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

US FDA approves Bristol Myers' blood cancer treatment

The U.S. FDA has approved Bristol Myers Squibb's combination treatment, iberdomide, for patients with a rare form of blood cancer called multiple myeloma. This treatment is intended for patients whose illness has relapsed or not responded to other therapies. Iberdomide works by targeting the …

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb has chosen Houston, Texas, as the location for its new state-of-the-art manufacturing facility. This 60,000-square-foot site represents a $2.3 billion investment and is projected to create 500 skilled jobs in Generation Park. Construction is set to begin next year, with the …

Autoline Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Did New Luxury Openings and Volatile Options Activity Just Shift Toll Brothers' (TOL) Investment Narrative?

In recent days, Toll Brothers, Inc. has opened several new luxury communities, including Fortune Ridge in Southeast, New York, Rivington Landing in Danbury, Connecticut, and Haven at Sea Bright in New Jersey, while also announcing final home opportunities at high-end developments in California, Georgia, …

Mettler Toledo Introduces Rapid Inspection Systems Delivery System

Mettler Toledo Product Inspection Group has launched LightningBuild, a program offering select product inspection systems with a four-week delivery time. This initiative includes the X12 LightningBuild X-ray inspection system and the C31 LightningBuild checkweigher, aiming to help food and pharmaceutical manufacturers quickly adapt to …

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A federal appeals court has reinstated a $6.7 billion lawsuit against Bristol Myers Squibb, brought by UMB Bank on behalf of former Celgene shareholders. The suit alleges Bristol Myers deliberately delayed FDA approvals for three drugs, including the cancer therapy Breyanzi, to avoid payouts …

Toll Brothers Announces New Waterfront Luxury Home Community Coming Soon to Yulee, Florida

Toll Brothers, Inc. Maris Cove offers waterfront living with expansive home designs in an exclusive gated community YULEE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Maris Cove, is …

Toll Brothers at Revera Luxury Home Community Opens in Richmond, Texas

Toll Brothers has opened a new luxury home community called Toll Brothers at Revera in Richmond, Texas, located approximately 30 miles southwest of Houston. The community features single-family homes with 3 to 5 bedrooms, ranging from 2,230 to 3,901 square feet, priced from the …

Autoliv Keeps Quarterly Dividend at $0.87 a Share, Payable Sept. 15 to Stockholders of Record Aug. 28

Autoliv, Inc. announced that it will keep its quarterly dividend at $0.87 per share. This dividend is scheduled to be paid on September 15 to stockholders of record as of August 28. The news was published on August 13, 2026.

Exploring Analyst Estimates for Toll Brothers (TOL) Q3 Earnings, Beyond Revenue and EPS

Equities Analysts Offer Predictions for AUTL Q3 Earnings

HC Wainwright raised its Q3 2026 EPS estimate for Autolus Therapeutics (NASDAQ:AUTL) to a loss of $0.20 per share from $0.21, maintaining a "Buy" rating and a $10 price target. Autolus Therapeutics reported a Q2 loss of $0.15 per share, beating expectations of $0.21, …

Autoline Industries Q1 Results: Revenue up 75% YoY to ₹2,654.7 lakh

Autoline Industries consolidated net profit rises 268.63% in the June 2026 quarter

How To Earn $500 A Month From Toll Brothers Stock Ahead Of Q3 Earnings

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Toll Brothers, Inc. has maintained regular dividend payments since 2017 and has increased its dividend payout annually for six consecutive years. Ahead of the company's third quarter …

Tolins Tyres Q1 Results FY27: Revenue Rs 79 crore, Net Profit Rs 6 Crore

Mettler Toledo International (MTD) Reports Stronger Earnings, Is The Stock Fully Valued?

Cytokinetics sues Bristol-Myers in patent case (CYTK:NASDAQ)

Cytokinetics has filed a lawsuit against Bristol-Myers Squibb and its acquisition MyoKardia. The suit aims to prevent a potential patent infringement case concerning Cytokinetics' heart disease treatment, Myqorzo (aficamten). The dispute involves U.S. Patent No. 12,616,697.

Toll Brothers (TOL) Opens New Luxury Communities In Four States

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Toll Brothers (NYSE:TOL) announced multiple new luxury community openings and final sale opportunities across several U.S. states. New launches include Toll Brothers at Fortune Ridge in New …

Die Bristol-Myers-Squibb-Aktie steigt nach Konsensstärke und solider Dividendenrendite

Mettler-Toledo International, Inc. (NYSE:MTD) Given Consensus Rating of "Hold" by Analysts

Mettler-Toledo International, Inc. (NYSE:MTD) has received a "Hold" consensus rating from analysts, with seven out of thirteen recommending holding the stock and six suggesting a buy. The average 12-month price target is set at approximately $1,461. The company recently surpassed quarterly earnings expectations, reporting …

Tolu Minerals (ASX:TOK): Tolukuma Drilling and Mine Restart Put PNG Gold Project in Focus

Tolins Tyres consolidated net profit declines 33.44% in the June 2026 quarter

Autoliv, Inc. (ALV) Stock Forecasts

Argus has lowered its target price for Autoliv Inc. (ALV) to $128.00, while the current price is $120.82. Autoliv is identified as a global leader in passive safety components for the automotive industry, including seat belts and airbags. The report is part of broader …

Bristol Myers Squibb (BMY) Invierte En Houston Y Reabre El Debate Sobre Su Valoración

Wells Fargo Remains a Buy on Toll Brothers (TOL)

Why Bristol Myers Squibb (BMY) Is Back In The Spotlight

Implied Volatility Surging for Toll Brothers Stock Options

Investors in Toll Brothers, Inc. TOL need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $65.00 Put had some of the highest implied volatility of all equity options today. What …

Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?

Bristol Myers Squibb recently announced it will invest about US$2.30 billion in a new 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, Texas, expected to support production of small molecules, biologics, and antibody-drug conjugates while creating nearly 500 skilled jobs and about …

Toll Brothers Donates $1.6 Million to Help HomeAid Build a Future Without Homelessness

Toll Brothers has donated over $1.6 million to HomeAid America, a national nonprofit dedicated to ending homelessness, following its 32nd Annual Gala. This donation supports HomeAid's mission through construction, community engagement, and educational initiatives for individuals and families experiencing or at risk of homelessness. …

Wedge Capital Management L L P NC Raises Stock Position in Bristol Myers Squibb Company $BMY

Handelsbanken Fonder AB Sells 446,938 Shares of Bristol Myers Squibb Company $BMY